Publications
Research, analysis, and a vision for new trade.
Our reports examine how the tools and processes of U.S. trade policy have drifted from the public interest — and chart what it would take to build something better.
Our Work
Trade policy, examined in plain language.
The Coalition publishes research and analysis aimed at one goal: making the choices, mechanisms, and consequences of U.S. trade policy understandable to the people it affects. Some of our work lays out a positive vision for what trade policy could be. Some takes a hard look at how today's tools — annual reports, enforcement priorities, negotiating mandates — have drifted from public purpose into corporate capture.
Below you'll find our complete library to date. Read them, share them, and let us know what you think — we've included a comment form at the bottom of this page, and we read every submission.
Library
Reports & Analysis
A growing collection of work on the future of U.S. trade policy.
2026 Trade Policy Agenda
Toward a more just global economy
Our vision for trade policy that connects to the interests of people and communities, raises standards instead of eroding them, and fosters a more just global economy. The Agenda is the foundation for everything else we publish — read it, share it, and let us know what you think.
Read the Agenda
The National Trade Estimate Report
Non-Tariff Barriers and Regulatory Capture
How the annual National Trade Estimate drifted from a neutral read on foreign barriers into a corporate-driven wish list — cited to justify sweeping tariffs and to challenge other countries' rules on drug pricing, tech platforms, consumer protections, and more.
Read the Report
Earth Day 2026
Is Protecting the Environment a Non-Tariff Barrier?
How the 2026 National Trade Estimate targets other countries' environmental protections — from carbon border adjustments and biofuels programs to plastic waste rules and battery labeling — treating efforts to safeguard people, animals, and the planet as non-tariff barriers to American trade.
Read the Report
Special 301
Deploying the Power of the U.S. Government to Line Big Pharma Pockets
How the annual Special 301 report has been captured by Big Pharma — used to pressure other countries, including developing nations, into stronger patent monopolies that limit access to life-saving medicines while drug companies funnel profits into buybacks and dividends.
Read the ReportJoin the Coalition
Become a supporter and help shape a trade policy that works for everyone.
Let Us Hear From You
Share your feedback.
Read something that resonated, raised a question, or sparked an idea? We read every submission and use this feedback to shape our work. Feedback on the 2026 Trade Policy Agenda is especially welcome.